• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 感染在中国-大流行前。

SARS-CoV-2 infection in China-Before the pandemic.

机构信息

Department of Clinical Data Center, The Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

The Guangdong Provincial Children's Medical Research Center, Guangzhou, China.

出版信息

PLoS Negl Trop Dis. 2020 Aug 6;14(8):e0008472. doi: 10.1371/journal.pntd.0008472. eCollection 2020 Aug.

DOI:10.1371/journal.pntd.0008472
PMID:32760070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7410170/
Abstract

In order to rapidly inform polices in the international response to the ongoing pandemic of coronavirus disease 19 (COVID-19), we summarize in this review current evidence on epidemiological and clinical features of the infection, transmission routes, problems of nucleic-acid testing, the epidemiological trend in China and impact of interventional measures, and some lessons learned. We concluded that the epidemic is containable with traditional nonpharmacological interventions, mainly through social distancing and finding and isolating suspected patients and close contacts. Nonpharmacological interventions are the only effective measures currently accessible and have suppressed some 90% of the infections in China. Close contacts are the major mechanism of transmission, which makes it possible to control this epidemic through nonpharmacological methods. Nucleic-acid testing alone may miss some 50% of infected patients, and other methods such as chest computerized tomography (CT) or serology should be considered to supplement molecular testing. The development of vaccines and drugs is important, but hesitation to make use of nonpharmacological interventions may mean missing golden opportunities for effective actions.

摘要

为了快速为国际上应对 2019 冠状病毒病(COVID-19)大流行的政策提供信息,我们在此综述了目前关于该感染的流行病学和临床特征、传播途径、核酸检测问题、中国的流行病学趋势和干预措施的影响,以及一些经验教训。我们的结论是,通过传统的非药物干预措施,主要是通过社会隔离以及发现和隔离疑似患者和密切接触者,该疫情是可以控制的。非药物干预措施是目前唯一可行的有效措施,已在中国抑制了约 90%的感染。密切接触是主要的传播机制,这使得通过非药物方法控制该流行病成为可能。单独进行核酸检测可能会漏诊约 50%的感染患者,因此应考虑使用胸部计算机断层扫描(CT)或血清学等其他方法来补充分子检测。疫苗和药物的研发很重要,但对非药物干预措施的犹豫不决可能意味着错失采取有效行动的黄金机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98f4/7410170/74b01c3b6aad/pntd.0008472.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98f4/7410170/f4ad13d4fc41/pntd.0008472.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98f4/7410170/74b01c3b6aad/pntd.0008472.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98f4/7410170/f4ad13d4fc41/pntd.0008472.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98f4/7410170/74b01c3b6aad/pntd.0008472.g002.jpg

相似文献

1
SARS-CoV-2 infection in China-Before the pandemic.SARS-CoV-2 感染在中国-大流行前。
PLoS Negl Trop Dis. 2020 Aug 6;14(8):e0008472. doi: 10.1371/journal.pntd.0008472. eCollection 2020 Aug.
2
The Wuhan SARS-CoV-2-What's next for China.武汉的新冠病毒——中国的下一步是什么。
J Med Virol. 2020 Jun;92(6):546-547. doi: 10.1002/jmv.25738. Epub 2020 Mar 18.
3
Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China.中国武汉医护人员家庭接触者中的无症状 SARS-CoV-2 感染。
Emerg Infect Dis. 2020 Aug;26(8):1930-1933. doi: 10.3201/eid2608.201016. Epub 2020 Apr 24.
4
COVID-19 pandemic-a focused review for clinicians.COVID-19 大流行——临床医生重点关注。
Clin Microbiol Infect. 2020 Jul;26(7):842-847. doi: 10.1016/j.cmi.2020.04.023. Epub 2020 Apr 25.
5
Epidemic curve and reproduction number of COVID-19 in Iran.伊朗新冠肺炎疫情曲线及再生数
J Travel Med. 2020 Aug 20;27(5). doi: 10.1093/jtm/taaa077.
6
Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Potential, Iran, 2020.严重急性呼吸综合征冠状病毒 2 传播潜力,伊朗,2020 年。
Emerg Infect Dis. 2020 Aug;26(8):1915-1917. doi: 10.3201/eid2608.200536. Epub 2020 Apr 22.
7
Epidemiological Investigation of the First 135 COVID-19 Cases in Brunei: Implications for Surveillance, Control, and Travel Restrictions.文莱首例 135 例 COVID-19 病例的流行病学调查:对监测、控制和旅行限制的启示。
Am J Trop Med Hyg. 2020 Oct;103(4):1608-1613. doi: 10.4269/ajtmh.20-0771.
8
What Should Gastroenterologists and Patients Know About COVID-19?胃肠病学家和患者应该了解哪些关于新冠病毒的知识?
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1409-1411. doi: 10.1016/j.cgh.2020.03.020. Epub 2020 Mar 18.
9
Age, source, and future risk of COVID-19 infections in two settings of Hong Kong and Singapore.香港和新加坡两地新冠病毒感染的年龄、感染源及未来风险
BMC Res Notes. 2020 Jul 13;13(1):336. doi: 10.1186/s13104-020-05178-z.
10
Modeling between-population variation in COVID-19 dynamics in Hubei, Lombardy, and New York City.建模湖北省、伦巴第和纽约市之间 COVID-19 动态的人群间变异。
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25904-25910. doi: 10.1073/pnas.2010651117. Epub 2020 Sep 24.

引用本文的文献

1
Facing stress and inflammation: From the cell to the planet.直面压力与炎症:从细胞到全球
World J Exp Med. 2024 Dec 20;14(4):96422. doi: 10.5493/wjem.v14.i4.96422.
2
Correction: SARS-CoV-2 infection in China-Before the pandemic.更正:新冠病毒在中国的感染——在疫情大流行之前。
PLoS Negl Trop Dis. 2022 Jun 6;16(6):e0010520. doi: 10.1371/journal.pntd.0010520. eCollection 2022 Jun.
3
Importance of public health tools in emerging infectious diseases.突发传染病中公共卫生工具的重要性。

本文引用的文献

1
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study.中国深圳 391 例病例及其 1286 名密切接触者的 COVID-19 流行病学和传播:一项回顾性队列研究。
Lancet Infect Dis. 2020 Aug;20(8):911-919. doi: 10.1016/S1473-3099(20)30287-5. Epub 2020 Apr 27.
2
Statistical and network analysis of 1212 COVID-19 patients in Henan, China.中国河南 1212 例 COVID-19 患者的统计和网络分析。
Int J Infect Dis. 2020 Jun;95:391-398. doi: 10.1016/j.ijid.2020.04.051. Epub 2020 Apr 24.
3
Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study.
BMJ. 2021 Dec 1;375:n2374. doi: 10.1136/bmj.n2374.
4
Data-driven identification of SARS-CoV-2 subpopulations using PhenoGraph and binary-coded genomic data.基于 PhenoGraph 和二进制编码基因组数据的数据驱动 SARS-CoV-2 亚群鉴定。
Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab307.
5
Community-Based Measures to Against the COVID-19: An Experience From Vietnam With Consecutive 3 Months of no New Infection in the Community During the First Wave of Pandemic.社区层面应对 COVID-19 的措施:越南在大流行第一波期间连续 3 个月无社区新增感染病例的经验。
Front Public Health. 2021 Jul 21;9:583655. doi: 10.3389/fpubh.2021.583655. eCollection 2021.
6
Gastrodin Inhibits Virus Infection by Promoting the Production of Type I Interferon.天麻素通过促进I型干扰素的产生来抑制病毒感染。
Front Pharmacol. 2021 Feb 19;11:608707. doi: 10.3389/fphar.2020.608707. eCollection 2020.
基于众包数据的 2019 年冠状病毒病早期流行病学分析:人群水平观察研究。
Lancet Digit Health. 2020 Apr;2(4):e201-e208. doi: 10.1016/S2589-7500(20)30026-1. Epub 2020 Feb 20.
4
Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.儿童感染 SARS-CoV-2 的特征及粪便中持续存在病毒的潜在证据。
Nat Med. 2020 Apr;26(4):502-505. doi: 10.1038/s41591-020-0817-4. Epub 2020 Mar 13.
5
A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations.新冠疫情期间中国人心理困扰的全国性调查:启示与政策建议
Gen Psychiatr. 2020 Mar 6;33(2):e100213. doi: 10.1136/gpsych-2020-100213. eCollection 2020.
6
COVID-19: protecting health-care workers.新型冠状病毒肺炎:保护医护人员。
Lancet. 2020 Mar 21;395(10228):922. doi: 10.1016/S0140-6736(20)30644-9.
7
Use of antiviral drugs to reduce COVID-19 transmission.使用抗病毒药物减少新冠病毒传播。
Lancet Glob Health. 2020 May;8(5):e639-e640. doi: 10.1016/S2214-109X(20)30114-5. Epub 2020 Mar 19.
8
Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak.可能与 COVID-19 疫情相关的 SARS-CoV-2 来自穿山甲。
Curr Biol. 2020 Apr 6;30(7):1346-1351.e2. doi: 10.1016/j.cub.2020.03.022. Epub 2020 Mar 19.
9
Transmission of COVID-19 in the terminal stages of the incubation period: A familial cluster.潜伏期末期的 COVID-19 传播:一个家族性聚集。
Int J Infect Dis. 2020 Jul;96:452-453. doi: 10.1016/j.ijid.2020.03.027. Epub 2020 Mar 16.
10
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures.新加坡三起 COVID-19 聚集性疫情调查:对监测和应对措施的启示。
Lancet. 2020 Mar 28;395(10229):1039-1046. doi: 10.1016/S0140-6736(20)30528-6. Epub 2020 Mar 17.